| Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts BE Hippen, A DeMattos, WJ Cook, CE Kew II, RS Gastona American journal of transplantation 5 (9), 2248-2252, 2005 | 183 | 2005 |
| In defense of a regulated market in kidneys from living vendors BE Hippen The Journal of medicine and philosophy 30 (6), 593-626, 2005 | 121 | 2005 |
| Organ sales and moral travails: lessons from the living kidney vendor program in Iran BE Hippen Cato Policy Analysis Series, 2008 | 79 | 2008 |
| In defense of a regulated system of compensation for living donation AJ Matas, B Hippen, S Satel Current Opinion in Organ Transplantation 13 (4), 379-385, 2008 | 75 | 2008 |
| Saving lives is more important than abstract moral concerns: financial incentives should be used to increase organ donation B Hippen, LF Ross, RM Sade The annals of Thoracic surgery 88 (4), 1053-1061, 2009 | 63 | 2009 |
| Risk, prognosis, and unintended consequences in kidney allocation BE Hippen, JR Thistlethwaite, LF Ross N Engl J Med 364 (14), 1285-1287, 2011 | 50 | 2011 |
| Does financial compensation for living kidney donation change willingness to donate? EJ Gordon, CH Patel, MW Sohn, B Hippen, LA Sherman American Journal of Transplantation 15 (1), 265-273, 2015 | 43 | 2015 |
| Survey of current transplant center practices regarding COVID-19 vaccine mandates in the United States BE Hippen, DA Axelrod, K Maher, R Li, D Kumar, Y Caliskan, T Alhamad, ... American Journal of Transplantation 22 (6), 1705-1713, 2022 | 36 | 2022 |
| Incentives for organ donation in the United States: feasible alternative or forthcoming apocalypse? B Hippen, A Matas Current Opinion in Organ Transplantation 14 (2), 140-146, 2009 | 33 | 2009 |
| The case for kidney markets B Hippen The New Atlantis, 47-61, 2006 | 28 | 2006 |
| When altruism is not enough: the worsening organ shortage and what it means for the elderly SL Satel, BE Hippen Elder LJ 15, 153, 2007 | 22 | 2007 |
| Was Sarah Murnaghan treated justly? J deSante, A Caplan, B Hippen, G Testa, J D. Lantos Pediatrics 134 (1), 155-162, 2014 | 20 | 2014 |
| A case study in unethical transgressive bioethics:“Letter of concern from bioethicists” about the prenatal administration of dexamethasone LB McCullough, FA Chervenak, RL Brent, B Hippen The American Journal of Bioethics 10 (9), 35-45, 2010 | 19 | 2010 |
| The kidney allocation score: methodological problems, moral concerns and unintended consequences B Hippen American Journal of Transplantation 9 (7), 1507-1512, 2009 | 19 | 2009 |
| Integrating kidney transplantation into value-based care for people with renal failure BE Hippen, FW Maddux American Journal of Transplantation 18 (1), 43-52, 2018 | 18 | 2018 |
| Mandating COVID-19 vaccination prior to kidney transplantation in the United States: no solutions, only decisions BE Hippen American Journal of Transplantation 22 (2), 381-385, 2022 | 16 | 2022 |
| Transplant clinician opinions on use of race in the estimation of glomerular filtration rate MD Doshi, N Singh, BE Hippen, KJ Woodside, P Mohan, HL Byford, ... Clinical Journal of the American Society of Nephrology 16 (10), 1552-1559, 2021 | 16 | 2021 |
| In defense of transplantation: A reply to Nancy Scheper-Hughes BE Hippen, JS Taylor American Journal of Transplantation 7 (7), 1695-1697, 2007 | 14 | 2007 |
| Implications of the Advancing American Kidney Health Initiative for kidney transplant centers BE Hippen, AI Reed, T Ketchersid, FW Maddux American Journal of Transplantation 20 (5), 1244-1250, 2020 | 13 | 2020 |
| Transplant tourism and unregulated black-market trafficking of organs T Starzl, L Teperman, D Sutherland, H Sollinger, J Roberts, C Miller, ... American Journal of Transplantation 9 (6), 1484, 2009 | 13 | 2009 |
Franklin W. Maddux, MD, FACPChief Medical Officer and Executive Vice President of Clinical and Scientific Affairs, FreseniusПодтвержден адрес электронной почты в домене fmc-na.com
